Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

InnoCan Pharma Stock Price, Quotes and Forecasts | OTC:INNPF | Benzinga

Q: What sector and industry does InnoCan Pharma (INNPF) operate in?

InnoCan Pharma is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Explore InnoCan Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INNPF.

Open	-
Close	-
Volume / Avg.	0 / 10.72K
Day Range	- - -
52 Wk Range	0.09 - 0.23
Market Cap	$39.19M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	999.99

Recent News

Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth

Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd.

Patricio Liddle

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark

Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.

Patricio Liddle

This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the U.S. Food and Drug Administration (FDA, for its Liposome-Cannabidiol (LPT-CBD) injectable treatment of chronic pain. With the move, the company initiated the regulatory process with the FDA for the approval of its prolonged CBD release technology for human use.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 10.72K
Day Range	- - -
52 Wk Range	0.09 - 0.23
Market Cap	$39.19M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	999.99

About

Sector

Healthcare

Industry

N/A

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy InnoCan Pharma (INNPF) stock?

You can purchase shares of InnoCan Pharma (OTCQB:INNPF) through any online brokerage.

View our list of the best stock brokerages

Who are InnoCan Pharma (INNPF) competitors?

There are no as such competitors for InnoCan Pharma.

What is the forecast, or price target, for InnoCan Pharma (INNPF) stock?

There is no analysis for InnoCan Pharma to provide a consensus price target.

What is the current price for InnoCan Pharma (INNPF)?

The stock price for InnoCan Pharma (OTCQB: INNPF) is $0.241 last updated September 21, 2023 at 9:10 AM EDT.

Does InnoCan Pharma (INNPF) pay a dividend?

A quarterly cash dividend of 0.37 per share of Class A Common Stock. The quarterly cash dividend was payable on November 29, 2024 to stockholders of record on November 15, 2024.

When is InnoCan Pharma (OTCQB:INNPF) reporting earnings?

InnoCan Pharma does not have any upcoming earnings scheduled.

Is InnoCan Pharma (INNPF) going to split?

There is no upcoming split for InnoCan Pharma.

What sector and industry does InnoCan Pharma (INNPF) operate in?

InnoCan Pharma is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Comments

InnoCan Pharma Stock Price, Quotes and Forecasts

InnoCan Pharma (INNPF) Forecast